StreetAlpha
13F holdings · Q3 2026

Lisanti Capital Growth

New York, NY · files as Lisanti Capital Growth, LLC
Know the moment Lisanti Capital Growth filesYou follow Lisanti Capital Growth An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 5, 2026Next filing due Feb 15, 2027CIK 1424467

Lisanti Capital Growth reported 95 stocks worth $373M in its 13F filing for Q3 2026, filed Nov 5, 2026. Its largest holdings are CORT (2.8%), HNGE (2.6%) and KNSA (2.6%). Compared with Q2 2026, the fund opened new positions in CDNA, GKOS and ELF, added to KNSA, MGNI and FIVN, trimmed CORT, HNGE and HTFL and sold out of BTSG, ALGM and MIRM.

Latest filing: what Lisanti Capital Growth did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
52 new13 added29 trimmed66 sold outBought about $201M · sold about $208M
New 52
See all 52 →
Added 13
See all 13 →
Trimmed 29
See all 29 →
Sold out 66
See all 66 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$373M−18.0% vs last quarter
Stocks held9552 new · 66 sold out
Top 5 weight12.7%spread out
Turnover130%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
CORT
Corcept Therapeutics Inc
$10.3M2.8%89K−2,260 (−2%)6 of 8
2
HNGE
Hinge Health Inc
$9.9M2.6%102K−37K (−27%)6 of 8
3
KNSA
Kiniksa Pharmaceuticals Intl
$9.6M2.6%129K+42K (+48%)3 of 8
4
MGNI
Magnite Inc
$9.1M2.5%361K+72K (+25%)7 of 8
5
CDNA
Caredx Inc
$8.5M2.3%130KNew position1 of 8
6
HTFL
Heartflow Inc
$7.7M2.1%155K−34K (−18%)5 of 8
7
ZETA
Zeta Global Holdings Corp
$7.7M2.1%245K−107K (−30%)8 of 8
8
GKOS
Glaukos Corp
$7.2M1.9%44KNew position4 of 8
9
FIVN
FIVE9 Inc
$6.8M1.8%201K+7,430 (+4%)2 of 8
10
ELF
E L F Beauty Inc
$6.5M1.7%64KNew position3 of 8
🔒 85 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
BTSG
Brightspring Health Svcs Inc
$10.8M155K
ALGM
Allegro Microsystems Inc
$7.5M108K
MIRM
Mirum Pharmaceuticals Inc
$7.4M63K
CRS
Carpenter Technology Corp
$7.2M12K
DY
Dycom Inds Inc
$7.2M14K

🔒 Free account: see all 30.

Reported value

last 8 quarters
$416MQ4 '24
$336MQ1 '25
$361MQ2 '25
$409MQ3 '25
$422MQ4 '25
$397MQ1 '26
$455MQ2 '26
$373MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 5, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Lisanti Capital Growth 13F FAQ

What does Lisanti Capital Growth own?

Lisanti Capital Growth reported 95 stocks worth $373M in its 13F filing for Q3 2026, filed Nov 5, 2026. Its largest holdings are CORT (2.8%), HNGE (2.6%) and KNSA (2.6%). The table above lists every position in the filing (the top 10 without an account).

What did Lisanti Capital Growth buy and sell in Q3 2026?

Compared with Q2 2026: 52 new positions, 13 added to, 29 trimmed and 66 sold out. New positions include CDNA, GKOS and ELF. It sold all of BTSG, ALGM and MIRM.

When will Lisanti Capital Growth file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Lisanti Capital Growth's portfolio worth?

The Q3 2026 filing reports $373M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.

From SEC Form 13F filings ยท Not investment advice